{"pmid":32445329,"title":"Caring of cancer patients during COVID-19: A real-life challenge.","text":["Caring of cancer patients during COVID-19: A real-life challenge.","Indian J Cancer","Adhikari, Shreya Das","Gupta, Nitin","Sharma, Atul","Deo, S V S","Bhatnagar, Sushma","32445329"],"journal":"Indian J Cancer","authors":["Adhikari, Shreya Das","Gupta, Nitin","Sharma, Atul","Deo, S V S","Bhatnagar, Sushma"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445329","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.4103/ijc.IJC_342_20","topics":["Prevention"],"weight":1,"_version_":1667600475798634496,"score":9.490897,"similar":[{"pmid":32405058,"title":"Caring for patients with cancer in the COVID-19 era.","text":["Caring for patients with cancer in the COVID-19 era.","The current COVID-19 pandemic challenges oncologists to profoundly re-organize oncological care in order to dramatically reduce hospital visits and admissions and therapy-induced immune-related complications without compromising cancer outcomes. Since COVID-19 is a novel disease, guidance by scientific evidence is often unavailable, and impactful decisions are inevitably made on the basis of expert opinions. Here we report how the seven comprehensive cancer centers of Cancer Core Europe have organized their healthcare systems at an unprecedented scale and pace to make their operations 'pandemic proof'. We identify and discuss many commonalities, but also important local differences, and pinpoint critical research priorities to enable evidence-based remodeling of cancer care during the COVID-19 pandemic. Also, we discuss how the current situation offers a unique window of opportunity for assessing the effects of de-escalating anticancer regimens, which may fast-forward the development of more-refined and less-toxic treatments. By sharing our joint experiences, we offer a roadmap for proceeding and aim to mobilize the global research community to generate the data that are critically needed to offer the best possible care to patients.","Nat Med","van de Haar, Joris","Hoes, Louisa R","Coles, Charlotte E","Seamon, Kenneth","Frohling, Stefan","Jager, Dirk","Valenza, Franco","de Braud, Filippo","De Petris, Luigi","Bergh, Jonas","Ernberg, Ingemar","Besse, Benjamin","Barlesi, Fabrice","Garralda, Elena","Piris-Gimenez, Alejandro","Baumann, Michael","Apolone, Giovanni","Soria, Jean Charles","Tabernero, Josep","Caldas, Carlos","Voest, Emile E","32405058"],"abstract":["The current COVID-19 pandemic challenges oncologists to profoundly re-organize oncological care in order to dramatically reduce hospital visits and admissions and therapy-induced immune-related complications without compromising cancer outcomes. Since COVID-19 is a novel disease, guidance by scientific evidence is often unavailable, and impactful decisions are inevitably made on the basis of expert opinions. Here we report how the seven comprehensive cancer centers of Cancer Core Europe have organized their healthcare systems at an unprecedented scale and pace to make their operations 'pandemic proof'. We identify and discuss many commonalities, but also important local differences, and pinpoint critical research priorities to enable evidence-based remodeling of cancer care during the COVID-19 pandemic. Also, we discuss how the current situation offers a unique window of opportunity for assessing the effects of de-escalating anticancer regimens, which may fast-forward the development of more-refined and less-toxic treatments. By sharing our joint experiences, we offer a roadmap for proceeding and aim to mobilize the global research community to generate the data that are critically needed to offer the best possible care to patients."],"journal":"Nat Med","authors":["van de Haar, Joris","Hoes, Louisa R","Coles, Charlotte E","Seamon, Kenneth","Frohling, Stefan","Jager, Dirk","Valenza, Franco","de Braud, Filippo","De Petris, Luigi","Bergh, Jonas","Ernberg, Ingemar","Besse, Benjamin","Barlesi, Fabrice","Garralda, Elena","Piris-Gimenez, Alejandro","Baumann, Michael","Apolone, Giovanni","Soria, Jean Charles","Tabernero, Josep","Caldas, Carlos","Voest, Emile E"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405058","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1038/s41591-020-0874-8","topics":["Prevention"],"weight":1,"_version_":1666802845377101825,"score":43.251076},{"pmid":32275294,"title":"Caring for Patients With Cancer During the COVID-19 Outbreak in Italy.","text":["Caring for Patients With Cancer During the COVID-19 Outbreak in Italy.","JAMA Oncol","Pietrantonio, Filippo","Garassino, Marina Chiara","32275294"],"journal":"JAMA Oncol","authors":["Pietrantonio, Filippo","Garassino, Marina Chiara"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275294","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1001/jamaoncol.2020.1426","locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666138491673640961,"score":41.060955},{"pmid":32415658,"title":"Caring for Patients with Rectal Cancer During the COVID-19 Pandemic.","text":["Caring for Patients with Rectal Cancer During the COVID-19 Pandemic.","The extraordinary spread of the novel coronavirus (COVID-19) has dramatically and rapidly changed the way in which we provide medical care for patients with all diagnoses. Conservation of resources, social distancing, and the risk of poor outcomes in COVID-19-positive cancer patients have forced practitioners and surgeons to completely rethink routine care. The treatment of patients with rectal cancer requires both a multidisciplinary approach and a significant amount of resources. It is therefore imperative to rethink how rectal cancer treatment can be aligned with the current COVID-19 pandemic paradigms. In this review, we discuss evidence-based recommendations to optimize oncological outcomes during the COVID-19 pandemic.","J Gastrointest Surg","Skowron, Kinga B","Hurst, Roger D","Umanskiy, Konstantin","Hyman, Neil H","Shogan, Benjamin D","32415658"],"abstract":["The extraordinary spread of the novel coronavirus (COVID-19) has dramatically and rapidly changed the way in which we provide medical care for patients with all diagnoses. Conservation of resources, social distancing, and the risk of poor outcomes in COVID-19-positive cancer patients have forced practitioners and surgeons to completely rethink routine care. The treatment of patients with rectal cancer requires both a multidisciplinary approach and a significant amount of resources. It is therefore imperative to rethink how rectal cancer treatment can be aligned with the current COVID-19 pandemic paradigms. In this review, we discuss evidence-based recommendations to optimize oncological outcomes during the COVID-19 pandemic."],"journal":"J Gastrointest Surg","authors":["Skowron, Kinga B","Hurst, Roger D","Umanskiy, Konstantin","Hyman, Neil H","Shogan, Benjamin D"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32415658","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s11605-020-04645-z","keywords":["covid-19","coronavirus","rectal cancer"],"topics":["Prevention"],"weight":1,"_version_":1666991242665263104,"score":41.060955},{"pmid":32419495,"title":"Impact of the COVID-19 Pandemic on Otolaryngology Residency: A Real-Life Experience.","text":["Impact of the COVID-19 Pandemic on Otolaryngology Residency: A Real-Life Experience.","The coronavirus disease (COVID-19) pandemic as been rapidly spreading worldwide. In our country, the entire Italian Healthcare System has been forced to adapt to this unprecedented condition in this century. The Head and Neck Department clinical and surgical activity was substantially reduced. In this situation, the Ear, Nose and Throat (ENT) residents in University Hospitals find themselves in an uncertain position; we are physicians, facing a deadly disease about which much remains unknown, but we are also trainees, and there is a high risk for our residency training to be affected. With this Letter, we would like to give a testimony of our experience and give some advices to bridge the training gap.","Ear Nose Throat J","De Luca, Pietro","Colacurcio, Vito","De Bonis, Egidio","Petrosino, Michele","Bisogno, Antonella","Troisi, Donato","Calvanese, Matteo","Marra, Pasquale","32419495"],"abstract":["The coronavirus disease (COVID-19) pandemic as been rapidly spreading worldwide. In our country, the entire Italian Healthcare System has been forced to adapt to this unprecedented condition in this century. The Head and Neck Department clinical and surgical activity was substantially reduced. In this situation, the Ear, Nose and Throat (ENT) residents in University Hospitals find themselves in an uncertain position; we are physicians, facing a deadly disease about which much remains unknown, but we are also trainees, and there is a high risk for our residency training to be affected. With this Letter, we would like to give a testimony of our experience and give some advices to bridge the training gap."],"journal":"Ear Nose Throat J","authors":["De Luca, Pietro","Colacurcio, Vito","De Bonis, Egidio","Petrosino, Michele","Bisogno, Antonella","Troisi, Donato","Calvanese, Matteo","Marra, Pasquale"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419495","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/0145561320926291","keywords":["covid-19","experience","otolaryngology residents","pandemic","residency"],"topics":["Prevention"],"weight":1,"_version_":1667159284494893056,"score":41.05969},{"pmid":32303717,"title":"Caring for our cancer patients in the wake of COVID-19.","text":["Caring for our cancer patients in the wake of COVID-19.","In response to our current global pandemic, unprecedented healthcare changes may have significant consequences for cancer patients in the United Kingdom. We explore why cancer patients may be more susceptible to severe infection and complications, highlighting various interventions that may help to ensure continuity of care in this unique cohort.","Br J Cancer","El-Shakankery, Karim Hussien","Kefas, Joanna","Crusz, Shanthini Mary","32303717"],"abstract":["In response to our current global pandemic, unprecedented healthcare changes may have significant consequences for cancer patients in the United Kingdom. We explore why cancer patients may be more susceptible to severe infection and complications, highlighting various interventions that may help to ensure continuity of care in this unique cohort."],"journal":"Br J Cancer","authors":["El-Shakankery, Karim Hussien","Kefas, Joanna","Crusz, Shanthini Mary"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303717","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1038/s41416-020-0843-5","locations":["United Kingdom"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Treatment"],"weight":1,"_version_":1666138491129430016,"score":40.332157}]}